Safety and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced patients: 24-week results of POWER 3.
Published in: Journal of Acquired Immune Deficiency Syndromes
Date of publication: September 1, 2007
Language: English
Bibliographic databases:
Cites articles
There is nothing here
Article -